Selskabets formål er at udvikle repositonerede lægemidler samt dermed beslægtet virksomhed.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 0 | -2 mio. | 2.2 mio. | 807 t. | - | |
CVR: 37509736
Previous names: ApS STM nr. 4310, Renoguard ApS, AKI Therapeutics ApS
Compared to 131 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Companies in the same industry and area
CVR 30082346
CVR 36494433
CVR 39161672
CVR 41489189
CVR 44807866
companydata.dk